Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
476,335,956
-
Share change
-
-16,005,487
-
Total reported value
-
$31,445,076,186
-
Put/Call ratio
-
39%
-
Price per share
-
$65.99
-
Number of holders
-
1,173
-
Value change
-
-$1,421,509,048
-
Number of buys
-
483
-
Number of sells
-
716
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q3 2024
As of 30 Sep 2024,
Edwards Lifesciences Corp - Common Stock (EW) was held by
1,173 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
476,335,956 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Bank of New York Mellon Corp, GEODE CAPITAL MANAGEMENT, LLC, Fisher Asset Management, LLC, JPMORGAN CHASE & CO, BROWN ADVISORY INC, and Ninety One UK Ltd.
This page lists
1,175
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.